|
Compound class:
Endogenous peptide in human, mouse or rat
Comment: Heterodimeric endogenous peptide ligand comprising subunits inhibin βA and inhibin βB. Interacts with type I and II activin receptors.
Species: Human
|
| References |
|
1. Gromada J, Latres E, Murphy A, Yancopoulos G, Morton L. (2017)
Anti-Activin A antibodies and uses thereof. Patent number: US9718881B2. Assignee: Regeneron Pharmaceuticals Inc. Priority date: 30/07/2014. Publication date: 01/08/2017. |